AN UPDATED REVIEW OFCANCER AND ANALYTICAL STUDY OF ANTICANCER DRUG GEFITINIB-THE FIRST SELECTIVE INHIBITOR OF EPIDERMAL GROWTH FACTOR RECEPTOR'S (EGFR)
Authors: Hafiz A. Makeen